IMpower150 Final Exploratory Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in Key NSCLC Patient Subgroups With EGFR Mutations or Metastases in the Liver or Brain
Naoyuki Nogami(Shikoku Cancer Center), Fabrice Barlési(Centre National de la Recherche Scientifique), Mark A. Socinski(Florida Hospital Cancer Institute), Martin Reck(German Center for Lung Research), Christian A. Thomas(New England Cancer Specialists), Federico Cappuzzo(Istituti di Ricovero e Cura a Carattere Scientifico), Tony Mok(Chinese University of Hong Kong), Gene Grant Finley(Allegheny Health Network), Joachim G.J.V. Aerts(Erasmus MC), Francesco Orlandi(Instituto Nacional del Tórax), Denis Moro‐Sibilot(Centre Hospitalier Universitaire de Grenoble), Robert M. Jotte(Texas Oncology), Daniil Stroyakovskiy(Moscow City Oncology Hospital №62), Liza C. Villaruz(UPMC Hillman Cancer Center), Delvys Rodríguez‐Abreu(Universidad de Las Palmas de Gran Canaria), Wan‐Teck Lim(National Cancer Centre Singapore), David M. Merritt, Shelley Coleman, Anthony Lee, Geetha Shankar(Amunix (United States)), Wei Yu, Ilze Bāra, Makoto Nishio(The Cancer Institute Hospital)
Cited by 298Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis